Last week, the Defense Health Agency (DHA) published a new strategic plan for the fiscal years of 2023 through 2028. Strategic plans are vague by nature, so gleaning specific, contract level investment intelligence from them tends to be impossible. They nevertheless can be helpful for understanding at least where an agency is heading. To that end, this week’s post takes a look at some of the advanced analytics and artificial intelligence/machine learning (AI/ML) investments listed in the plan for the DHA over the next five years.
The DHA anticipates that the analysis capabilities of the MHS GENESIS system will enable robust data analysis. In addition, however, the DHA intends to invest in prescriptive and predictive analytics capabilities to enhance patient care and to improve the administration of that care by providers…
Source: Advanced Analytics and AI/ML Investment in the Defense Health Agency’s Strategic Plan. September 20, 2023. Deltek.
Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $250 annually.